Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2026 ▲▼ | Q2 2026 ▲▼ | Change ▲▼ | Q1 2026 ▲▼ | Q2 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Relay Therapeutics, Inc.(RLAY) | 17,000,000 | 12,000,000 | -5,000,000 | $169.15M | $224.52M | 13.37% | +$55.37M |
| ENLIVEN THERAPEUTICS INC | 3,275,000 | 3,275,000 | 0 | $128.38M | $166.21M | 9.90% | +$37.83M |
| Alkermes plc(ALKS) | 4,200,000 | 3,000,000 | -1,200,000 | $148.51M | $157.19M | 9.36% | +$8.67M |
| Cogent Biosciences, Inc.(COGT) | 2,888,007 | 3,050,000 | +161,993 | $111.16M | $118.03M | 7.03% | +$6.88M |
| Amylyx Pharmaceuticals, Inc.(AMLX) | 5,650,000 | 5,650,000 | 0 | $78.53M | $101.47M | 6.04% | +$22.94M |
| Definium Therapeutics, Inc.(DFTX) | 2,000,000 | 2,000,000 | 0 | $37.80M | $94.08M | 5.60% | +$56.28M |
| Spyre Therapeutics, Inc.(SYRE) | 1,912,380 | 846,786 | -1,065,594 | $96.46M | $75.18M | 4.48% | -$21.28M |
| Alto Neuroscience, Inc.(ANRO) | 2,723,196 | 2,723,196 | 0 | $61.22M | $71.87M | 4.28% | +$10.65M |
| Tango Therapeutics, Inc.(TNGX) | 0 | 2,250,000 | +2,250,000 | $0 | $70.33M | 4.19% | +$70.33M |
| EYEPOINT INC | 2,825,000 | 4,600,000 | +1,775,000 | $36.41M | $65.78M | 3.92% | +$29.37M |
| Tyra Biosciences, Inc.(TYRA) | 2,475,000 | 1,875,000 | -600,000 | $94.79M | $59.89M | 3.57% | -$34.91M |
| Damora Therapeutics, Inc.(DMRA) | 1,939,000 | 1,939,000 | 0 | $50.22M | $50.43M | 3.00% | +$213.3K |
| Celldex Therapeutics, Inc.(CLDX) | 2,696,616 | 1,350,000 | -1,346,616 | $85.54M | $50.23M | 2.99% | -$35.30M |
| PHARVARIS N V COM | 1,918,970 | 1,425,000 | -493,970 | $54.21M | $49.28M | 2.93% | -$4.93M |
| LB Pharmaceuticals Inc(LBRX) | 1,500,000 | 1,500,000 | 0 | $36.99M | $48.68M | 2.90% | +$11.69M |
| ASSEMBLY BIOSCIENCES INC | 1,000,000 | 1,415,000 | +415,000 | $27.75M | $38.88M | 2.32% | +$11.13M |
| EDITAS MEDICINE INC | 0 | 8,889,000 | +8,889,000 | $0 | $28.80M | 1.72% | +$28.80M |
| Kymera Therapeutics, Inc.(KYMR) | 750,000 | 250,000 | -500,000 | $62.47M | $28.67M | 1.71% | -$33.80M |
| PERSPECTIVE THERAPEUTICS INC | 6,336,782 | 6,336,782 | 0 | $26.42M | $21.61M | 1.29% | -$4.82M |
| CENTURY THERAPEUTICS INC | 8,695,652 | 8,695,652 | 0 | $19.65M | $21.30M | 1.27% | +$1.65M |
| ZURA BIO LTD | 3,250,000 | 3,250,000 | 0 | $19.34M | $19.18M | 1.14% | -$162.5K |
| AVALO THERAPEUTICS INC | 483,000 | 1,018,319 | +535,319 | $7.21M | $18.82M | 1.12% | +$11.61M |
| INFLARX NV | 0 | 7,300,000 | +7,300,000 | $0 | $16.35M | 0.97% | +$16.35M |
| AN2 THERAPEUTICS INC | 2,333,713 | 2,933,680 | +599,967 | $7.98M | $14.20M | 0.85% | +$6.22M |
| NUVALENT INC | 833,600 | 100,000 | -733,600 | $85.40M | $12.35M | 0.74% | -$73.05M |
| SAB BIOTHERAPEUTICS INC | 4,401,500 | 2,870,000 | -1,531,500 | $16.86M | $11.19M | 0.67% | -$5.66M |
| INHIBIKASE THERAPEUTICS INC | 5,397,488 | 5,397,488 | 0 | $9.07M | $10.96M | 0.65% | +$1.89M |
| RELMADA THERAPEUTICS INC | 633,901 | 1,425,000 | +791,099 | $4.41M | $9.86M | 0.59% | +$5.45M |
| PEPGEN INC | 4,475,000 | 4,475,000 | 0 | $7.92M | $8.05M | 0.48% | +$134.3K |
| RESEARCH ALLIANCE CORP III | 0 | 500,000 | +500,000 | $0 | $5.35M | 0.32% | +$5.35M |
| HELIX ACQUISITION CORP III | 500,000 | 500,000 | 0 | $5.08M | $5.32M | 0.32% | +$240.0K |
| LEONABIO INC | 464,398 | 464,398 | 0 | $4.77M | $4.27M | 0.25% | -$506.2K |
| VISTAGEN THERAPEUTICS INC | 0 | 2,788,620 | +2,788,620 | $0 | $630.2K | 0.04% | +$630.2K |
| CORVUS PHARMACEUTICALS INC | 2,258,735 | 0 | -2,258,735 | $33.05M | $0 | — | -$33.05M |
| Erasca, Inc.(ERAS) | 3,175,000 | 0 | -3,175,000 | $51.37M | $0 | — | -$51.37M |
| KARYOPHARM THERAPEUTICS INC | 1,950,000 | 0 | -1,950,000 | $10.86M | $0 | — | -$10.86M |
| Nurix Therapeutics, Inc.(NRIX) | 2,275,000 | 0 | -2,275,000 | $35.26M | $0 | — | -$35.26M |
| Ocular Therapeutix, Inc.(OCUL) | 2,575,000 | 0 | -2,575,000 | $21.81M | $0 | — | -$21.81M |
| PALISADE BIO INC | 7,181,062 | 0 | -7,181,062 | $12.57M | $0 | — | -$12.57M |
| SOLENO THERAPEUTICS INC | 652,432 | 0 | -652,432 | $21.84M | $0 | — | -$21.84M |
| Xenon Pharmaceuticals Inc.(XENE) | 825,000 | 0 | -825,000 | $47.97M | $0 | — | -$47.97M |